Valeant Pharmaceuticals International Inc
(NYSE : VRX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Loading VRX News...
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
VRXValeant Pharmaceuticals International, Inc.
-1.06%10.759.9%$297.33m
PRGOPerrigo Co. Plc
-0.29%67.964.8%$179.65m
SHPGShire PLC Sponsored ADR
0.70%175.230.3%$161.46m
MDCOMedicines Company
1.40%50.6922.6%$134.46m
ENDPEndo International Plc
-0.20%9.978.9%$131.03m
JAZZJazz Pharmaceuticals Plc
0.45%143.141.9%$89.29m
MNKMallinckrodt Plc
-0.21%43.0912.8%$86.79m
UTHRUnited Therapeutics Corporation
0.66%140.0511.5%$85.74m
PRXLPAREXEL International Corporation
0.86%62.356.7%$70.21m
PCRXPacira Pharmaceuticals, Inc.
-0.11%46.9016.9%$67.17m
PTLAPortola Pharmaceuticals, Inc.
0.55%38.4410.3%$48.48m
ICPTIntercept Pharmaceuticals, Inc.
0.80%116.7322.8%$45.29m
HZNPHorizon Pharma plc
-1.31%14.379.7%$45.07m
GWPHGW Pharmaceuticals PLC Sponsored ADR
0.04%121.179.9%$39.39m
ICLRICON Plc
1.73%78.942.8%$38.72m

Company Profile

Valeant Pharmaceuticals International, Inc. is a pharmaceutical company which engages in developing, manufacturing, and marketing pharmaceutical products in the areas of dermatology, eye health, neurology, and generics. It operates through the Developed Markets and Emerging Markets. The Developed Markets segment offers over-the-counter and medical products as well as alliance and contract service revenues, in the areas of dermatology and podiatry, neurology, gastrointestinal disorders, eye health, oncology and urology, dentistry, aesthetics, and women's health. The Emerging Markets consists of branded generic pharmaceutical and branded pharmaceuticals; over-the-counter and medical device products. The company was founded on March 29, 1994 and is headquartered in Laval, Canada.